-
Je něco špatně v tomto záznamu ?
Early-Onset Neonatal Sepsis: Inflammatory Biomarkers and MicroRNA as Potential Diagnostic Tools in Preterm Newborns
P. Janec, M. Mojžíšek, M. Pánek, M. Haluzík, J. Živný, J. Janota
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
Grantová podpora
NU20-07-00109
Agentura Pro Zdravotnický Výzkum České Republiky
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
ProQuest Central
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
38583178
DOI
10.14712/fb2023069050173
Knihovny.cz E-zdroje
- MeSH
- biologické markery metabolismus MeSH
- interleukin-18 MeSH
- kojenec MeSH
- lidé MeSH
- mikro RNA * genetika MeSH
- novorozenec MeSH
- novorozenecká sepse * diagnóza MeSH
- sepse * diagnóza genetika MeSH
- vaskulární endoteliální růstový faktor A MeSH
- zánět MeSH
- Check Tag
- kojenec MeSH
- lidé MeSH
- novorozenec MeSH
- Publikační typ
- časopisecké články MeSH
Mortality and morbidity of newborns with sepsis can be improved by early and accurate diagnosis and targeted therapy. To evaluate the early molecular events associated with inflammation and infection, we evaluated markers of endothelial activation and injury and circulating plasma miRNAs in preterm newborns with sepsis. The study group consisted of newborns with gestational age ≤ 32 weeks, with culture-positive early-onset neonatal sepsis (sepsis group, N = 8), and as a control group, we enrolled newborns without sepsis (control group, N = 12). Soluble markers of inflammation were measured using Luminex-based multiplex assay. Platelet-free plasma RNA was used to construct the library for miRNA sequencing analysis. Normalized counts were calculated and used to measure differential expression of individual detected miRNAs. We found a significant increase of interleukin 18 (IL-18) in the cord blood of the sepsis group (mean ± SEM, 104.7 ± 30.4 pg/ml vs 52.7 ± 5.6 pg/ml, P = 0.02). In peripheral blood of sepsis group patients, we found a significant increase of VEGF-A compared to controls (196.0 ± 70.5 pg/ml vs 59.6 ± 8.5 pg/ml, P = 0.02). In the cord blood plasma, eight miRNAs had significantly differential expression (P < 0.05), four miRNAs were up-regulated and four miRNAs down-regulated. In peripheral blood plasma, all nine miRNAs with significant differential expression were up-regulated. In conclusion, in early-onset neonatal sepsis, IL-18 and VEGF-A might be considered in diagnostic workup. Early-onset sepsis in preterm newborns is associated with significant changes in the circulating miRNA pattern.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24008638
- 003
- CZ-PrNML
- 005
- 20250121094620.0
- 007
- ta
- 008
- 240509s2023 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.14712/fb2023069050173 $2 doi
- 035 __
- $a (PubMed)38583178
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Janec, Petr $u Department of Neonatology, Masaryk Hospital Ústí nad Labem, Krajská zdravotní, Ústí nad Labem, Czech Republic $7 xx0109414
- 245 10
- $a Early-Onset Neonatal Sepsis: Inflammatory Biomarkers and MicroRNA as Potential Diagnostic Tools in Preterm Newborns / $c P. Janec, M. Mojžíšek, M. Pánek, M. Haluzík, J. Živný, J. Janota
- 520 9_
- $a Mortality and morbidity of newborns with sepsis can be improved by early and accurate diagnosis and targeted therapy. To evaluate the early molecular events associated with inflammation and infection, we evaluated markers of endothelial activation and injury and circulating plasma miRNAs in preterm newborns with sepsis. The study group consisted of newborns with gestational age ≤ 32 weeks, with culture-positive early-onset neonatal sepsis (sepsis group, N = 8), and as a control group, we enrolled newborns without sepsis (control group, N = 12). Soluble markers of inflammation were measured using Luminex-based multiplex assay. Platelet-free plasma RNA was used to construct the library for miRNA sequencing analysis. Normalized counts were calculated and used to measure differential expression of individual detected miRNAs. We found a significant increase of interleukin 18 (IL-18) in the cord blood of the sepsis group (mean ± SEM, 104.7 ± 30.4 pg/ml vs 52.7 ± 5.6 pg/ml, P = 0.02). In peripheral blood of sepsis group patients, we found a significant increase of VEGF-A compared to controls (196.0 ± 70.5 pg/ml vs 59.6 ± 8.5 pg/ml, P = 0.02). In the cord blood plasma, eight miRNAs had significantly differential expression (P < 0.05), four miRNAs were up-regulated and four miRNAs down-regulated. In peripheral blood plasma, all nine miRNAs with significant differential expression were up-regulated. In conclusion, in early-onset neonatal sepsis, IL-18 and VEGF-A might be considered in diagnostic workup. Early-onset sepsis in preterm newborns is associated with significant changes in the circulating miRNA pattern.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a kojenec $7 D007223
- 650 12
- $a mikro RNA $x genetika $7 D035683
- 650 12
- $a novorozenecká sepse $x diagnóza $7 D000071074
- 650 _2
- $a interleukin-18 $7 D020382
- 650 _2
- $a vaskulární endoteliální růstový faktor A $7 D042461
- 650 _2
- $a biologické markery $x metabolismus $7 D015415
- 650 12
- $a sepse $x diagnóza $x genetika $7 D018805
- 650 _2
- $a zánět $7 D007249
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mojžíšek, Marek $u Neonatal Unit, Department of Obstetrics and Gynaecology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $7 xx0327811
- 700 1_
- $a Pánek, Martin, $u Department of Neonatology, Masaryk Hospital Ústí nad Labem, Krajská zdravotní, Ústí nad Labem, Czech Republic $d 1974- $7 mzk2006337208
- 700 1_
- $a Haluzík, Martin, $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic $d 1970- $7 xx0000707
- 700 1_
- $a Živný, Jan $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic. jzivny@LF1.cuni.cz $7 xx0115576
- 700 1_
- $a Janota, Jan, $u Department of Neonatology, Thomayer University Hospital, Prague, Czech Republic. jan.janota@fnmotol.cz $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic. jan.janota@fnmotol.cz $u Neonatal Unit, Department of Obstetrics and Gynaecology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic. jan.janota@fnmotol.cz $d 1968- $7 stk2007405368
- 773 0_
- $w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 69, č. 5-6 (2023), s. 173-180
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38583178 $y Pubmed
- 910 __
- $a ABA008 $b A 970 $c 89 $y p $z 0
- 990 __
- $a 20240509 $b ABA008
- 991 __
- $a 20250121094617 $b ABA008
- 999 __
- $a ok $b bmc $g 2247162 $s 1218419
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 69 $c 5-6 $d 173-180 $e - $i 0015-5500 $m Folia biologica $n Folia Biol (Praha) $x MED00011004
- GRA __
- $a NU20-07-00109 $p Agentura Pro Zdravotnický Výzkum České Republiky
- LZP __
- $b NLK138 $a Pubmed-20240509